Golden has been acquired by ComplyAdvantage.Read about it here ⟶

Karus Therapeutics

Karus Therapeutics is a company developing cancer therapeutics.

Overview Structured Data Issues Contributors Activity

karustherapeutics.com

Is a

Company

Organization

Company attributes

Industry

Biology

Biomedical engineering

Location

AngelList URL

angel.co/karus-therapeutics

Pitchbook URL

pitchbook.com/profiles.../54813-79

Full Address

Building 173, The Innovation Centre, Harwell Campus, Didcot, Oxfordshire OX11 0QG0

Investors

New Leaf Venture Partners

SV Health Investors

Esperante Ventures

International Biotechnology Trust

Total Funding Amount (USD)

7,600,000

Latest Funding Round Date

September 6, 2012

Latest Funding Type

Series B Round

Patents Assigned (Count)

Wellfound ID

karus-therapeutics

Country

United Kingdom

Other attributes

Company Operating Status

Active

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like Karus Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API